Infusion of Stem Cells over Two Days in Studying the Engraftment, Transplant Related Toxicity and Outcomes in Pediatric Patients Undergoing Stem Cell Transplantation at King Faisal Special Hospital and Research Center, Riyadh, Saudi Arabia from 2020 to 2023

Puntos clave

• Engraftment success was documented in pediatric patients undergoing stem cell transplantation, indicating potential benefits of the procedure.
• Over the two-year span from 2020 to 2023, toxicity outcomes showed a notable relationship with the type of stem cell infused in the subjects' treatment regimen.
• Observational analysis spanning multiple pediatric cases from 2020 to 2023 outlines various engagement and outcomes associated with stem cell infusion.
• The findings indicate a need for ongoing exploration of toxicity effects following stem cell infusion, particularly in pediatric populations.